A widely available antiviral medication offers new possibilities for long Covid patients seeking relief from debilitating ...

The expensive medication does little to prevent hospitalisation or death for people who are vaccinated against the virus, a ...

Two new Omicron subvariants are gaining ground in the U.S. as some people report experiencing respiratory symptoms like ...

Pfizer (NYSE:PFE) recently announced positive topline results from its Phase 3 BASIS study for HYMPAVZI™ and declared a third ...

PFE faces a decline in COVID revenues, LOE pressure and IRA impacts but rising EPS estimates offer a glimmer of resilience.

Adriana Alatorre was in peak condition, running at least 30 miles a week before a mild bout of COVID knocked her off her feet ...

Pfizer's cost-cutting boosts earnings despite revenue miss. Discover its growth strategy, strong drug portfolio & potential ...

Safe dividend-paying income stocks trading under $30 are passive income home runs. Stocks trading under the $30 level offer Boomers a larger share count when they buy. With the geopolitical ...

Many of the protections and behaviours that helped us during the pandemic — like staying home when sick, wearing masks, and ...

It has now been over six months since the FDA authorized Paxlovid in December 2021 “for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older ...

Three supercharged dividend stocks have the tools and intangibles to fatten investors' pocketbooks in June, and well beyond.